Is thioredoxin the physiological vitamin K epoxide reducing agent?
- 6 July 1992
- journal article
- Published by Wiley in FEBS Letters
- Vol. 305 (3) , 257-259
- https://doi.org/10.1016/0014-5793(92)80681-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Vitamin K epoxide and quinone reductase activitiesBiochemical Pharmacology, 1990
- Inhibition Of Thioredoxin Reductase (E.C. 1.6.4.5.) By Antitumor QuinonesFree Radical Research Communications, 1990
- Vitamin K, 2,3-Epoxide And Quinone Reduction: Mechanism And InhibitionFree Radical Research Communications, 1990
- Protein disulfide isomerase: Multiple roles in the modification of nascent secretory proteinsCell, 1989
- Reduced thioredoxin: A possible physiological cofactor for vitamin k epoxide reductase. further support for an active site disulfideBiochemical and Biophysical Research Communications, 1988
- Identification of a Warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reductionBiochemistry, 1985
- Indirect inhibition of vitamin K epoxide reduction by salicylateJournal of Pharmacy and Pharmacology, 1984
- Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomesBiochemistry, 1983
- Vitamin K dependent carboxylase: subcellular location of the carboxylase and enzymes involved in Vitamin K metabolism in rat liverBiochemistry, 1980
- Tissue distribution and subcellular localization of bovine thioredoxin determined by radioimmunoassayBiochemistry, 1978